このページの読み込み中にエラーが発生したようです.
当社チームに通知しましたが、問題が続くようでしたらEメールサポートウィジェットを使ってご連絡ください。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 6.3x - 6.9x | 6.6x |
| Selected Fwd EBIT Multiple | 44.6x - 49.3x | 47.0x |
| Fair Value | $1.87 - $2.17 | $2.02 |
| Upside | 4.7% - 21.4% | 13.0% |
| Benchmarks | Ticker | Full Ticker |
| Simply Better Brands Corp. | SBBC | TSXV:SBBC |
| Bausch Health Companies Inc. | BHC | TSX:BHC |
| C21 Investments Inc. | CXXI | CNSX:CXXI |
| Lexaria Bioscience Corp. | LEXX | NasdaqCM:LEXX |
| Tilray Brands, Inc. | TLRY | TSX:TLRY |
| Medexus Pharmaceuticals Inc. | MEDX.F | OTCPK:MEDX.F |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| SBBC | BHC | CXXI | LEXX | TLRY | MEDX.F | ||
| TSXV:SBBC | TSX:BHC | CNSX:CXXI | NasdaqCM:LEXX | TSX:TLRY | OTCPK:MEDX.F | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | 6.8% | NM- | NM- | NM- | NM- | |
| 3Y CAGR | NM- | 3.0% | -42.5% | NM- | NM- | 159.6% | |
| Latest Twelve Months | -0.5% | 15.2% | -55.9% | -23.4% | 39.6% | 17.6% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | -11.3% | 18.1% | 7.4% | -1665.6% | -20.9% | 2.0% | |
| Prior Fiscal Year | -14.8% | 18.5% | 13.8% | -2841.3% | -27.7% | 7.9% | |
| Latest Fiscal Year | -13.3% | 19.4% | 6.5% | -1226.7% | -12.2% | 11.3% | |
| Latest Twelve Months | -8.4% | 19.4% | 6.5% | -1458.3% | -12.0% | 13.7% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 0.90x | 2.52x | 1.07x | 47.45x | 0.89x | 0.83x | |
| EV / LTM EBITDA | -16.9x | 7.8x | 11.4x | -3.3x | 23.7x | 4.3x | |
| EV / LTM EBIT | -10.8x | 13.0x | 16.3x | -3.3x | -7.5x | 6.0x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -10.8x | -3.3x | 16.3x | ||||
| Historical EV / LTM EBIT | -7.1x | 5.6x | 27.6x | ||||
| Selected EV / LTM EBIT | 6.3x | 6.6x | 6.9x | ||||
| (x) LTM EBIT | 15 | 15 | 15 | ||||
| (=) Implied Enterprise Value | 94 | 99 | 104 | ||||
| (-) Non-shareholder Claims * | (31) | (31) | (31) | ||||
| (=) Equity Value | 63 | 68 | 73 | ||||
| (/) Shares Outstanding | 32.3 | 32.3 | 32.3 | ||||
| Implied Value Range | 1.95 | 2.10 | 2.25 | ||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 1.95 | 2.10 | 2.25 | 1.79 | |||
| Upside / (Downside) | 8.8% | 17.4% | 26.0% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | SBBC | BHC | CXXI | LEXX | TLRY | MEDX.F | |
| Enterprise Value | 79 | 24,192 | 28 | 24 | 738 | 89 | |
| (+) Cash & Short Term Investments | 4 | 1,181 | 2 | 8 | 252 | 8 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 7 | 0 | |
| (-) Debt | (6) | (21,839) | (11) | (0) | (374) | (40) | |
| (-) Other Liabilities | 0 | (957) | 0 | 0 | 19 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 77 | 2,577 | 19 | 32 | 643 | 58 | |
| (/) Shares Outstanding | 107.2 | 367.9 | 120.0 | 17.6 | 937.7 | 32.3 | |
| Implied Stock Price | 0.72 | 7.00 | 0.16 | 1.82 | 0.69 | 1.79 | |
| FX Conversion Rate to Trading Currency | 0.70 | 0.70 | 0.70 | 1.00 | 0.70 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1.03 | 10.00 | 0.23 | 1.82 | 0.98 | 1.79 | |
| Trading Currency | CAD | CAD | CAD | USD | CAD | USD | |
| FX Rate to Reporting Currency | 0.70 | 0.70 | 0.70 | 1.00 | 0.70 | 1.00 | |